Catalyst Wire Dossier Catalyst Wire Dossier

Oral recombinant salmon calcitonin (rsCT)

salmon calcitonin · Tarsa Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral recombinant salmon calcitonin (rsCT), covering 2014-09-12 to 2014-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis [Phase 2]

See pricing